Silvia Novello, MD, PhD is Full Professor of Medical Oncology in the Oncology Department at San Luigi Hospital in Orbassano, Italy, part of the University of Turin.
Silvia Novello
Researcher
Professor Novello is presently Professor of Medical Oncology at the Department of Oncology of the University of Turin, Italy. Her previous positions include: ...
Silvia Novello, MD, PhD, of the University of Turin, discusses phase III results from the ITACA trial, which explored the notion of improving survival by ...
It is approved for use post-crizotinib in ALK+ mNSCLC based on phase II trial (ALTA) data, and significantly improved progression-free survival (PFS) vs ...
NOVELLO Silvia, MD, PhD. Institute: Full Professor of Medical Oncology at the Department of Oncology at the University of Turin, Italy.
Silvia Novello, MD, PhD, assistant professor, Thoracic Oncology Unit, University of Turin, San Luigi Hospital, Orbassano, Italy, discusses immunotherapy and ...
Duration: 4:30
Posted: Feb 4, 2021
Posted: Feb 4, 2021
Pemetrexed (Alimta) possesses broad antitumor activity. It has beenevaluated in non–small-cell lung cancer (NSCLC) as front-line chemotherapyin a comprehensive ...
NOVELLO Silvia. Nome: Silvia. Cognome: NOVELLO. Contatti. Email: silvia.novello@unito.it. Sede di lavoro. ONCOLOGIA. Regione Gonzole, 10. 10043 ORBASSANO.